Radar-based imaging system for non-invasive tracking of gold nanoparticles

Researcher:
Prof. Avi Schroeder | Chemical Engineering

Categories:

Pharmaceuticals and Biotechnology

The Technology

This technology introduces a non-invasive deep-tissue imaging system that uses millimeter-wave (mmWave) radar to detect and track gold nanoparticles (GNPs) in biological tissues. The system transmits low-power, non-ionizing radar signals and analyzes their reflections to localize and monitor the spatial distribution of GNPs inside the body. These FDA-approved nanoparticles are known for accumulating in tumor sites and crossing the blood-brain barrier, making them ideal for diagnostic and therapeutic tracking.
Using frequency-modulated continuous wave (FMCW) radar and a custom signal-processing algorithm, the system generates range-angle maps that precisely identify GNP location and concentration. This allows the system to perform non-contact imaging through barriers such as the skull or soft tissue, enabling 2D or 3D visualization of GNPs used in drug delivery systems or as standalone diagnostic markers.

Advantages

  • Non-ionizing, safe alternative to CT/MRI
  • Real-time imaging through biological barriers
  • Detects both presence and concentration of GNPs
  • Compact, low-cost, radar-based setup
  • Allowing simultaneous monitoring of multiple individuals
  • Enables monitoring over time

Applications and Opportunities

  • Tissue imaging and tumor localization
  • Tracking nanoparticle-based drug delivery
  • Imaging for photothermal or photodynamic therapies
  • Companion diagnostics in cancer and additional diseases
  • Monitoring how GNPs accumulate, move, or clear from tissues
arrow Business Development Contacts
Dr. Mor Goldfeder
Director of Business Development, life Sciences